具有成本效益的心力衰竭管理:对铁缺乏心力衰竭患者输液铁疗法的分析
Phyo Thazin Myint1, Phoo Pwint Nandar2, Aye M Thet3
1Department of Hospital Medicine, Baystate Medical Center, Springfield, MA, USA.
概括
静脉注射铁 (IV铁) 减少了铁缺乏症患者的心力衰竭住院的情况. 这种治疗也可以改善生活质量并降低医疗保健成本.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 缺铁是心力衰竭患者常见的并发症.
- 静脉注射铁有望改善心力衰竭患者的生活质量并减少住院治疗的可能性.
- 关于IV铁在心力衰竭中的疗效的临床试验结果各不相同.
研究的目的:
- 为了评估静脉注射铁对缺铁心力衰竭患者的影响.
- 评估支持该人群使用IV铁的证据质量.
- 提供可用的临床试验数据的综合元分析.
主要方法:
- 在PubMed和Cochrane数据库中进行了系统的搜索,截至2021年10月.
- 包括随机临床试验,至少12周的随访比较IV铁与安慰剂在缺铁心力衰竭患者.
- 用随机效应模型分析结果,用GRADE方法评估证据质量.
主要成果:
- 七项研究被纳入了元分析.
- 静脉注射铁显著降低了心力衰竭住院的风险13.8% (或0.59;等级:低).
- 心力衰竭住院或心血管死亡的综合结局被IV铁减少了17.5% (或0.51;等级:中等). 所有原因和心血管死亡率没有显著差异.
结论:
- 静脉注射铁与铁缺乏症患者心力衰竭住院减少有关.
- 静脉注射铁是一种具有成本效益的干预措施,有可能提高患者的生活质量并降低医疗保健支出.
- 这些发现支持对符合条件的心力衰竭患者进行静脉注射铁疗法的考虑.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:26Heart Failure Drugs: Inotropic Agents
578
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
578
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370